Roche's personalized cancer treatment wins FDA approval

Roche's personalized cancer treatment wins FDA approval

9:55 AM, 16th August 2019
Roche Logo

BASEL, SWITZERLAND: The US Food and Drug Administration approved Roche Holding AG's personalized cancer treatment, which targets tumors with specific genetic mutations, irrespective of where in the body the disease started, the agency said.

The treatment, Rozlytrek, is a tyrosine kinase inhibitor that targets patients who must be identified via genetic profiling. It is approved to treat certain types of solid tumors, which show rare genetic anomalies called NTRK fusions.

Individually, the mutations are rare and it is difficult to run dedicated tests for each. They have been identified in a broad range of solid tumor types, including breast, colorectal, pancreatic and non-small cell lung cancers, the company said.

Since these NTRK fusions occur in a multitude of tumors, Roche sees potentially broad application for Rozlytrek, in conjunction with diagnostic tests from its Foundation Medicine unit.

Rozlytrek, already approved in Japan, is now available in the United States for adults and children 12 years of age and older, the company said.

Roche did not disclose the pricing details of the drug in its statement. It did not immediately respond to Reuters request.

The FDA also approved it to treat adult patients with non-small cell lung cancer, whose tumors show a genetic mutation called ROS1 fusion.

Rival treatment Vitrakvi from German drugmaker Bayer has already won US backing for solid tumors that test positive for NTRK genes.

Source: Reuters



Your Comments (Up to 2000 characters)
Please respect our community and the integrity of its participants. WOC reserves the right to moderate and approve your comment.

Related News

Hengli announces successful startup of world's largest dehydrogenation plant

MUNICH, GERMANY: Hengli Group has successful started its new dehydrogenation plant in Dalian, China. The plant uses Clariant’s Catofin catalyst ...

Read more
Domo Chemicals to acquire Solvay’s European polyamides business

GHENT, BELGIUM: Domo Chemicals has signed an agreement to acquire Solvay’s performance polyamides business in Europe. This includes engineering ...

Read more
PPG completes acquisition of Dexmet Corporation

PITTSBURGH, US: PPG Industries has completed its acquisition of Dexmet Corporation, a manufacturer of specialty materials for surfaces in aerospace, a ...

Read more
Major fire breaks at Alkyl Amines plant in Pune, India

MUMBAI, INDIA: A major fire broke out at a chemical plant in Kurkumbh MIDC area of Pune district's Daund tehsil on Wednesday night, a police official ...

Read more
Ecolab acquires US-based cleaning solutions provider Chemstar

ST PAUL, US: Ecolab Inc has acquired the business of privately held Chemstar Corporation, a US-based supplier of food safety and cleaning and sanitizi ...

Read more
Unichem Lab gets FDA approval for pain management drug

NEW DELHI, INDIA: Unichem Laboratories has received Abbreviated New Drug Application (ANDA) approval from US Food & Drug Administration (USFD ...

Read more uses cookies to ensure that we give you the best experience on our website. By using this site, you agree to our Privacy Policy and our Terms of Use. X